Uncategorized Archives - Page 29 of 956

WednesdayAug 27, 2025 9:45 am

Safe Pro Group Inc. (NASDAQ: SPAI) Closes $8M Private Placement with Drone Industry Investors: Ondas Holdings, Unusual Machines

Proceeds will support commercialization of Safe Pro’s AI-powered defense and security technologies, including SPOTD and NODE, and could expand to $20 million through warrant exercises. The company’s AI has processed 1.78 million drone images in Ukraine, detecting over 31,600 explosive threats. Expanding military budgets for drones and AI, alongside global demining needs, highlight a strong and growing market opportunity. Safe Pro Group (NASDAQ: SPAI), an emerging provider of drone-based AI-powered security and threat detection solutions, has closed an $8 million private placement with strategic investors Ondas Holdings Inc. (NASDAQ: ONDS) and Unusual Machines Inc. (NYSE: UMAC), both leaders in the…

WednesdayAug 27, 2025 9:00 am

Octane Presents Cardiovascular Tech Forum 2025

Octane, Southern California’s leading accelerator for technology and medical innovation, will host its Cardiovascular Tech Forum 2025 on September 11–12 at VEA Newport Beach, A Marriott Resort & Spa. The two-day forum will unite industry leaders, entrepreneurs, physicians, and investors to explore the future of cardiovascular innovation and shape the next generation of patient care. The forum will feature a keynote address from Dr. John B. Simpson, PhD, MD, a pioneering interventional cardiologist and serial entrepreneur who invented the over-the-wire balloon angioplasty catheter, a groundbreaking advancement that transformed cardiovascular treatment. Dr. Simpson has founded seven companies, including Advanced Cardiovascular Systems,…

TuesdayAug 26, 2025 12:00 pm

Izotropic Corp. (CSE: IZO) (OTCQB: IZOZF) Unveils Comprehensive Brand Identity Transformation to Position Company for Commercial Launch

The company's rebranding reflects Izotropic's refined corporate positioning and emphasizes its focus on key people across the healthcare ecosystem Izotropic's strategic positioning becomes even more critical when considering the magnitude of the opportunity ahead Izotropic has the exclusive global licensing rights to breast CT technology, and IzoView is the commercial model As Izotropic (CSE: IZO) (OTCQB: IZOZF) positions itself to capture a share of the $8.7 billion global breast imaging market projected by 2030 (https://nnw.fm/25YQE), the company has unveiled a strategic brand transformation that signals its readiness to commercialize two decades of breakthrough medical research. Izotropic holds exclusive global licensing…

TuesdayAug 26, 2025 11:45 am

Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) Leads U.S. Effort to Reduce REE Dependence with Transformative Technology

The U.S. remains heavily dependent on China for rare earth processing and refined components critical to defense, electronics and clean-energy applications. An independent evaluation confirmed that RapidSX can separate both light and heavy REEs using proven conventional chemistry but dramatically faster kinetics. Ucore’s broader vision includes disrupting China’s control over the REE industry by introducing scalable, high-efficiency separation technology. The race to secure rare earth elements has become a matter of both economic survival and national security for the United States, as China continues to dominate the global supply chain for these critical resources. At the center of America’s push…

TuesdayAug 26, 2025 10:30 am

PowerBank Corporation (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2), Announces $1.74 Million Grant to Advance Nova Scotia Community Solar Projects, for Which PowerBank is Lead Developer

The three projects, Sydney, Brooklyn, and Petpeswick, will generate a combined 12.4 MW DC of clean energy. Funding is provided by Nova Scotia’s Department of Energy and managed by Net Zero Atlantic. PowerBank is the lead developer for the owner, working alongside local partner Trimac Engineering. The projects are part of Canada’s first Community Solar Program, targeting 80% renewable energy by 2030. PowerBank has completed over 100 MW of projects and holds a pipeline exceeding 1 GW across North America. Disseminated on behalf of PowerBank Corporation PowerBank (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2), a premier developer and owner of…

TuesdayAug 26, 2025 9:45 am

Soligenix Inc. (NASDAQ: SNGX) Reports Major Clinical Trial Milestones, Strategic Progress in Rare Disease Treatment Pipeline

CEO reports confidence about late-stage rare disease pipeline and upcoming key development milestones. Soligenix’s recent accomplishments reflect substantial momentum across its specialized biotherapeutics and public health solutions business segments. The company's pipeline diversification strategy extends beyond CTCL treatment to encompass multiple therapeutic areas. With pivotal phase 3 cancer trial results due in 2026 and multiple fast-tracked therapies advancing through late-stage development, Soligenix (NASDAQ: SNGX) stands at the threshold of potentially transforming treatment paradigms for rare diseases affecting millions of underserved patients worldwide. The Soligenix pipeline includes a novel photodynamic drug therapy, along with other innovative drug and vaccine technology, to…

TuesdayAug 26, 2025 9:00 am

GlobalTech Corp. (GLTK) Is ‘One to Watch’

GlobalTech balances internal innovation with strategic acquisitions to accelerate growth and long-term value creation. The company’s flagship platforms span multiple high-growth domains including enterprise productivity, e-commerce, digital lending, and compliance. Its majority stake in WorldCall Telecom Ltd. supports infrastructure-led value creation in Pakistan’s telecommunications sector. Strategic alliances with regional players such as Omantel anchor GlobalTech’s expansion into key international markets like the Middle East. GlobalTech (OTC: GLTK) is a U.S.-based technology holding company specializing in artificial intelligence (“AI”), big data, and digital infrastructure. Advancing toward a Nasdaq listing, the company balances internal innovation with strategic acquisitions to accelerate growth and…

MondayAug 25, 2025 2:45 pm

Vision Marine Technologies Inc. (NASDAQ: VMAR) Expands Distribution Network, Signs Exclusive Nimbus Boats Agreement for Florida’s West Coast

The agreement is a milestone in VMAR’s strategic evolution from a specialized electric propulsion manufacturer to a comprehensive marine retail powerhouse. The strategic importance of this partnership becomes evident when considering Florida's dominant position in the American boating market. This distribution agreement follows Vision Marine's transformative June 2025 acquisition of Nautical Ventures. In a bold move to dominate America's most lucrative boating market, Vision Marine Technologies (NASDAQ: VMAR) has locked in exclusive distribution rights for premium Nimbus Boats throughout Florida's West Coast, positioning the company to capture a significant slice of the state's massive $6.4 billion annual powerboat sales (https://nnw.fm/2HGBx).…

MondayAug 25, 2025 2:00 pm

D-Wave Quantum Inc. (NYSE: QBTS) Targets Processor Development Scalability with Advanced Cryogenic Packaging Initiative

D-Wave launches initiative to develop advanced cryogenic packaging for both gate-model and annealing quantum processors. The program will expand multichip packaging capabilities, manufacturing equipment, and processes. Initiative leverages expertise from NASA’s Jet Propulsion Laboratory (“JPL”) for superconducting bump-bond technology. The goal is to increase interconnectivity and scalability for architectures reaching 100,000 qubits. D-Wave Quantum Inc. (NYSE: QBTS) (“D-Wave”), a leader in quantum computing systems, software, and services, has announced a strategic development program to expand its capabilities in cryogenic packaging, designed to advance and scale both gate-model and annealing quantum processors. The initiative underscores the company’s focus on hardware innovation…

MondayAug 25, 2025 1:15 pm

Lantern Pharma Inc. (NASDAQ: LTRN) Reports Q2 Results with Clinical Trial, AI Platform Advancements

Lantern Pharma completed enrollment in its LP-184 Phase 1a trial and is preparing Phase 1b/2 studies in cancers with large market potential. Early patient responses across LP-184, LP-284, and LP-300 trials highlight clinical activity in difficult-to-treat cancers. Intellectual property expanded with new European patent allowance for LP-284 and publication of blood-brain barrier prediction patent. Enhancements to RADR(R), the company’s AI platform, include public launch of predictBBB.ai(TM) and a new drug combination module. Lantern ended Q2 with $15.9 million in cash and expects its runway to extend into mid-2026. R&D expenses declined year-over-year, reflecting disciplined cost control while advancing multiple trials.…

Financial news and publishing for public and private companies

Contact us: 512.354.7000

Category: Uncategorized